PRESS RELEASE:

Spectrum Solutions Names Rohit Gupta as Chief Medical Officer

Leslie Titus Bryant, Director of Marketing & Brand
April 6th, 2021

Spectrum announced today it has appointed Rohit K. Gupta to the newly established position of Chief Medical Officer. Rohit is a highly respected researcher who brings nearly 20 years of experience advancing new areas of growth in the life sciences with biobanking to improve infrastructure related to clinical biospecimens and biological data.

As Chief Medical Officer at Spectrum Solutions, Rohit will be responsible for the strategy, direction, and execution of Spectrum’s clinical and medical product development plans. Rohit’s leadership will steer Spectrum’s R&D efforts and continue to drive product innovation.

“Spectrum Solutions has gained a reputation for forward-thinking ingenuity and for developing and bringing to market industry-changing innovations,” said Stephen Fanning, CEO of Spectrum Solutions. “Rohit is a welcome addition to our team. His exceptional track record in establishing new research modalities and infrastructures will be a tremendous asset as we continue to extend our product offerings and enter new markets to better serve the evolving, global needs of the life sciences and healthcare markets.”

Rohit began his research in 2003 at Stanford University studying Multiple Sclerosis. He became a founding member and Executive Director of the Stanford Biobank, where he established a globally recognized biobank infrastructure. He achieved notoriety as he led the strategy, design, and development of a federation of academic biobanks utilizing novel tools, such as a central data platform for managing both clinical and biological ‘transomics’ information related to the biospecimens. His research expertise in the life sciences has helped fund more than $100M in support across various projects.

Rohit went on to serve as the inaugural Chief Biobank Officer for the University of California, San Francisco (UCSF), where he led campus-wide efforts to establish centralized specimen and data management solutions for the next generation of diagnostics and therapeutics.

Rohit Gupta, Chief Medical Officer

Concurrent to his position at Spectrum Solutions, Rohit also serves as the Chief Biobank Officer for TMRW Life Sciences,

a life sciences technology company which provides the world’s first automated cryo-management solution for IVF.

Ultimately, his vision includes efforts to advance sample quality, foster cutting-edge assays, and drive a patient-centric informatics approach to help unlock the value of precision medicine and scientific discovery.

Rohit is frequently published in numerous peer-reviewed medical journals. Some of his recent collaborative efforts include: “Clonal replacement of tumor-specific T cells following PD-1 blockade” in Nature Medicine and “PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity” in Nature.

PRESS RELEASE:

Spectrum Solutions Names Rohit Gupta as Chief Medical Officer

Leslie Titus Bryant, Director of Marketing & Brand
April 6th, 2021

Spectrum announced today it has appointed Rohit K. Gupta to the newly established position of Chief Medical Officer. Rohit is a highly respected researcher who brings nearly 20 years of experience advancing new areas of growth in the life sciences with biobanking to improve infrastructure related to clinical biospecimens and biological data.

As Chief Medical Officer at Spectrum Solutions, Rohit will be responsible for the strategy, direction, and execution of Spectrum’s clinical and medical product development plans. Rohit’s leadership will steer Spectrum’s R&D efforts and continue to drive product innovation.

“Spectrum Solutions has gained a reputation for forward-thinking ingenuity and for developing and bringing to market industry-changing innovations,” said Stephen Fanning, CEO of Spectrum Solutions. “Rohit is a welcome addition to our team. His exceptional track record in establishing new research modalities and infrastructures will be a tremendous asset as we continue to extend our product offerings and enter new markets to better serve the evolving, global needs of the life sciences and healthcare markets.”

Rohit began his research in 2003 at Stanford University studying Multiple Sclerosis. He became a founding member and Executive Director of the Stanford Biobank, where he established a globally recognized biobank infrastructure. He achieved notoriety as he led the strategy, design, and development of a federation of academic biobanks utilizing novel tools, such as a central data platform for managing both clinical and biological ‘transomics’ information related to the biospecimens. His research expertise in the life sciences has helped fund more than $100M in support across various projects.

Rohit went on to serve as the inaugural Chief Biobank Officer for the University of California, San Francisco (UCSF), where he led campus-wide efforts to establish centralized specimen and data management solutions for the next generation of diagnostics and therapeutics.

Concurrent to his position at Spectrum Solutions, Rohit also serves as the Chief Biobank Officer for TMRW Life Sciences, a life sciences technology company which provides the world’s first automated cryo-management solution for IVF.

Ultimately, his vision includes efforts to advance sample quality, foster cutting-edge assays, and drive a patient-centric informatics approach to help unlock the value of precision medicine and scientific discovery.

Rohit is frequently published in numerous peer-reviewed medical journals. Some of his recent collaborative efforts include: “Clonal replacement of tumor-specific T cells following PD-1 blockade” in Nature Medicine and “PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity” in Nature.

Rohit Gupta, Chief Medical Officer

Rohit Gupta New Medical Officer

Access this press release on Business Wire

Our Team, Helping your Team, get Back in the Game!

How you collect saliva makes a big diagnostic difference.
Real-world mass testing scenarios require an authorized, proven, and supported system that mitigates any risk of exposure and a company that holds a blackbelt in scalability.
Get your business back in the game.

blank

PROUD PARTNER OF MLB

™/© 2020 MLB

Get to Know Our #PartoftheSolution

Who is Spectrum Solutions?

Headquartered in Salt Lake City, Utah, Spectrum is a life science, medical device manufacturing company focusing its fully-integrated industry expertise on creating forward-looking, and scalable, end-to-end solutions for clinical diagnostic projects and commercialized product plans. A single-source provider of innovative medical device engineering & product manufacturing, molding, chemical formulation, packaging design, customized kitting, & direct-to-user fulfillment, Spectrum’s bio-sample collection devices, patented technologies, and dedicated services deliver measurable process optimization, unprecedented efficiency, and unmatched global scalability.

#partoftheSolution

Leslie Titus Bryant Spectrum Solutions SpokesmanSpectrum Corporate Spokesman
Leslie Titus Bryant
Director of Marketing & Brand
admin@spectrumsolution.com

Tim Rush Public Relations, Springboard 5Media Contact
Tim Rush, Springboard5
801-208-1100
tim.rush@springboard5.com

Get to Know Our #PartoftheSolution

Who is Spectrum Solutions?

Headquartered in Salt Lake City, Utah, Spectrum Solutions is a life science and medical device manufacturing company that focuses its fully-integrated industry expertise on creating forward-looking and scalable end-to-end solutions for clinical diagnostic projects and commercialized product plans. Spectrum is a single-source provider of innovative medical device engineering & product manufacturing, molding, chemical formulation, packaging design, customized kitting, & direct-to-user fulfillment. Its bio-sample collection devices, patented technologies, and dedicated services deliver measurable process optimization, unprecedented efficiency, and unmatched global scalability.

#partoftheSolution

Leslie Titus Bryant Spectrum Solutions SpokesmanSpectrum Corporate Spokesman
Leslie Titus Bryant
Director of Marketing & Brand
admin@spectrumsolution.com

Tim Rush Public Relations, Springboard 5Media Contact
Tim Rush, Springboard5
801-208-1100
tim.rush@springboard5.com

Spectrum
in the News

Spectrum
in the News

Health is a dynamic state of wellbeing. Healthcare providers and researchers have long believed that changes in our saliva record our ongoing state-of-health story. This encrypted source of individual truth, and how to best use it, delivers us all a quicker path to informed decisions and treatments free of adverse reactions.

Interestingly, saliva acts as a wide resource of genomic information useful for identifying and monitoring in real-time a disease as well as its state of progression. Saliva analysis looks at the cellular level, the biologically active compounds, making it a true representative of what is clinically relevant.

Spectrum’s technically-superior saliva collection systems have not only been engineered to lead the saliva collection industry in molecular diagnostics and clinical research applications but deliver the safest, most robust biomaterial for the earliest detection and diagnosis of disease and infection.

  • Saliva provides the earliest path to critical detection and diagnosis
  • Saliva contains the entire library of proteins, hormones, antibodies, and other molecular compounds measured in routine blood tests
  • First EUA authorized saliva collection device for COVID-19 testing & authorized device for direct-to-patient at-home sample self-collection
  • Used in supervised & unsupervised sample collection LDT workflows of symptomatic & asymptomatic users
  • Pain-free, non-invasive, & safe – ideal for those needing frequent & repeat testing
  • In-device live virus inactivation at ambient temps (COVID-19 EUA validated data)
  • Eliminates hooded containment of samples arriving at the testing lab
  • No temperature-controlled storage or transport of collected saliva samples
  • Single device for DNA & viral RNA applications
  • Safest collection approach & most robust biomaterial for detecting COVID-19
  • Delivers 99.998% highest levels of testing accuracy & sensitivity
  • Formulation identifies infections at its earliest stage from as few as 200 copies/ml (lateral flow rapid tests need 10,000-20,000 copies/ml)
  • A single preserved saliva sample provides opportunity for multiple tests
  • Over two weeks of post-collection stability with no degradation in sample efficacy
  • System maintains critical bio-sample consistency
  • Mass-testing scalability & easy device integration using validated and supported processes
  • Mitigates any risk of infection throughout the testing process
  • Pinpoint life-cycle stage of active viral infection
  • Eliminates UN3373 shipping designation with clearance from USPS, FedEx, & UPS
  • Delivers the highest levels of testing accuracy using qualified extraction chemistries
Questions? Let’s Connect
Contact Us

Are you a lab?
Let’s connect.

#partofthesolution

How can we help?
Let’s Chat

Looking for a customized testing or life science product solution? Benefit from our experience, industry understanding, and process support.